Analyst Upgrades: The Coca-Cola Co, Amedisys Inc, and Sunrun Inc

Analysts upwardly revised their ratings and price targets on The Coca-Cola Co (KO), Amedisys Inc (AMED), and Sunrun Inc (RUN)

Mar 10, 2016 at 9:29 AM
facebook twitter linkedin


Analysts are weighing in on food and beverage stock The Coca-Cola Co (NYSE:KO), health care company Amedisys Inc (NASDAQ:AMED), and solar energy concern Sunrun Inc (NASDAQ:RUN). Here's a quick roundup of today's bullish brokerage notes on KO, AMED, and RUN.

  • KO is edging higher in electronic trading, thanks to a price-target increase to $51 from $47 at RBC. The Coca-Cola Co hit a one-year high of $44.83 on Wednesday, before closing at $44.81, and is now ahead 4.3% year-to-date. The stock could stand to benefit from further bullish analyst attention -- at present, 10 of 18 brokerage firms rate KO a "hold" or worse. Meanwhile, short-term option traders continue to be optimistic -- the equity's Schaeffer's put/call open interest ratio (SOIR) of 0.37 is lower than 95% of all readings taken in the past year.
  • Oppenheimer raised its price target on AMED to $45 from $40, after the company reported better-than-expected fourth-quarter earnings earlier this week. Amedisys Inc has added 34% since hitting a year-to-date low of $32.18 in early February, and closed at $42.72 on Wednesday -- above their 200-day moving average for the first time since Jan. 22. While the stock has been a strong performer of late, speculative players have shown a preference for puts over calls. Specifically, AMED's SOIR of 1.41 sits in the 86th annual percentile.
  • Deutsche Bank initiated coverage on RUN with a "buy" rating and $15 price target -- a 126% premium over the stock's Wednesday close of $6.65, and in never-before-seen territory -- citing optimism over Sunrun Inc's cost structure, valuation, and business model. As a result, the shares, which have been on the mend since an early-February drop, are set to pop 5.3% at the open. The company is due to report quarterly earnings after the market closes tonight, and though three out of four analysts call RUN a "buy" or better, it appears a fair number of traders wouldn't mind a negative reaction -- 13% of the equity's available float is currently sold short, representing nearly seven sessions' worth of trading, at RUN's typical daily volume.
Sign up now for Schaeffer's Opening View newsletter to get a head start on all the major pre-market news!
 

Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 

 


 


 
Special Offers from Schaeffer's Trading Partners